No Data
No Data
Director J Singleton Sells 20,786 Shares of Viking Therapeutics Inc (VKTX)
Deutsche Bank praises Eli Lilly and Co (LLY.US) as a "high-growth unicorn", with a target price skyrocketing to $1025.
Deutsche Bank has upgraded its rating on Eli Lilly and Co (LLY.US) from "hold" to "buy" with a target price increase from $725 to $1025.
Buy Russell 1000 Health Care Growth, Says Oppenheimer in Highlighting Top Sector Ideas
10 Health Care Stocks With Whale Alerts In Today's Session
Buy Rating on Viking Therapeutics: Promising VK2735 Development and Strategic Advancements
What Eli Lilly, Novo Nordisk Earnings Reveal About the Future of GLP-1 Sales
No Data
105535782 : ok